August 2024 Labs in Court
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
When structuring business arrangements, addressing six key risk areas can help laboratories avoid major compliance issues.
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
Case is a recent example of the trend toward Medicare schemes involving telehealth, cancer genetic testing, and kickbacks.